IMNM
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Immunome doses the first patient in a Phase 1 trial of IM-3050, an FAP-targeted radioligand therapy for advanced solid tumorsJul 21, 2026
- FDA accepted Immunome's new drug application for varegacestat to treat adults with desmoid tumorsJul 8, 2026
- Immunome dosed the first patient in a Phase 1 trial of IM-1617 for advanced solid tumorsJun 11, 2026
- Immunome submitted an NDA to the U.S. FDA for Varegacestat to treat adults with desmoid tumorsApr 29, 2026
- Immunome announces positive topline results from Phase 3 RINGSIDE trial of varegacestat in desmoid tumorsDec 15, 2025